International Journal of Cardiology
Volume 127, Issue 1 , Pages 33-39 , 23 June 2008

Effects of different statins on endothelial nitric oxide synthase and AKT phosphorylation in endothelial cells

  • Juyong Wang

      Affiliations

    • Tumor Institute of Traditional Chinese Medicine, Longhua Hospital; Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    • Corresponding Author InformationCorresponding author. Tumor Institute of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 Southern of Wan Ping Road, 69# box, Shanghai, China. Tel.: +86 21 64385700 2320, +86 13761470296; fax: +86 21 64398310.
    • ,
  • Zhenye Xu

      Affiliations

    • Tumor Institute of Traditional Chinese Medicine, Longhua Hospital; Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    • ,
  • Isao Kitajima

      Affiliations

    • Department of Clinical Laboratory and Molecular Pathology, University of Toyama, Toyama 930-0194, Japan
    • ,
  • Zhongqi Wang

      Affiliations

    • Tumor Institute of Traditional Chinese Medicine, Longhua Hospital; Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China

Received 15 March 2007 ,Revised 16 August 2007 ,Accepted 27 October 2007.

References 

  1. Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1998;95:8880–8885
  2. Lefer AM, Campbell B, Shin YK, Scalia R, Hayward R, Lefer DJ. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation. 1999;100:178–184
  3. Maron DJ, Fazio S, Linton MF. Current perspectives on statin. Circulation. 2000;101:207–213
  4. John S, Delles C, Jacobi J, et al. Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. J Am Coll Cardiol. 2001;37:1351–1358
  5. Kajinami K, Takekoshi N, Saito Y. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev. 2003;21:199–215
  6. Fujino H, Saito T, Tsunenari Y, Kojima J. Interaction between several medicines and statin. Arzneimittelforschung. 2003;53:145–153
  7. Yamasaki H, Fujino H, Kanazawa M, et al. Pharmacological and pharmacokinetic features and clinical efforts of pitavastatin. Folia Pharmacol Jpn. 2004;123:349–362
  8. Wang J, Tokoro T, Matsui K, Higa S, Kitajima I. Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K AKT pathway in endothelial cells. Life Sci. 2005;76:2257–2268
  9. Kojima H, Sakurai K, Kikuchi K, et al. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem Pharm Bull. 1998;46:373–375
  10. Nakatsubo N, Kojima H, Kikuchi K, et al. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett. 1998;427:263–266
  11. Harris MB, Ju H, Venama VJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. J Biol Chem. 2001;276:16587–16591
  12. Michell BJ, Chen Z, Tiganis T, et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem. 2001;276:17625–17628
  13. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. Circ Res. 2001;88:E68–E75
  14. Dimmeler S, Fleming I, Fisslthler B, Hermann C, Busse R, Zeiher A. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601–605
  15. Gallis B, Corhals GL, Goodlett DR, et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem. 1999;274:30101–30108
  16. Cosentino F. Statins in cardiovascular disease. Role of Rho/Rho kinase inhibition and of Akt activation. Recent Prog Med. 2003;94:444–450
  17. Skaletz-Rorowski A, Lutchman M, Kureishi Y, Lefer DJ, Faust JR. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res. 2003;57:253–264
  18. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Br Med J. 2003;326:1423
  19. Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation. 2002;105:739–745
  20. Ohkita M, Sugii M, Ka Y, et al. Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells. Exp Biol Medicine (Maywood). 2006;231(6):772–776
  21. Tokoro T, Wang J, Kitajima I. The novel HMG-CoA reductase inhibitor, pitavastatin, induces a protective action in vascular endothelial cells through the production of nitric oxide (NO). Yakugaku Zasshi. 2004;124:121–126
  22. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol. 2002;64:749–774
  23. Hattori Y, Nakanishi N, Akimoto K, Yoshida M, Kasai K. HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23(2):176–182
  24. Kajinami K, Mabuchi H, Saito Y. NK-104: novel synthetic HMG-CoA reductase inhibitor. Exp Opin Invest Drugs. 2000;9:2653–2661
  25. Aoki T, Nishimura H, Nakagawa S, et al. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung. 1997;47:904–909
  26. Bao W, Hu E, Tao L, et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc Res. 2004;62:548–558
  27. Mocanu MM, Bell RM, Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol. 2002;34:661–668
  28. Murphy E, Tong H, Steenbergen C. Preconditioning: is the Akt-ion in the PI3K pathway?. J Mol Cell Cardiol. 2003;35:1021–1025
  29. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 2004;61:448–460
  30. Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6:1004–1010
  31. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597–601
  32. Igarashi J, Bernier SG, Michel T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem. 2001;276:12420–12426
  33. Mukai Y, Shimokawa H, Matoba T, et al. Acute vasodilator effects of HMG-CoA reductase inhibitors: involvement of PI3-kinase/Akt pathway and Kv channels. J Cardiovasc Pharmacol. 2003;42:118–124
  34. Champion HC, Bivalacqua TJ, Greenberg SS, Giles TD, Hyman AL, Kadowitz PJ. Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice. Proc Natl Acad Sci U S A. 2002;99:13248–13253
  35. Murata T, Kinoshita K, Hori M, et al. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2005;25:2335–2342
  36. Yoshitomi Y, Ishii T, Kaneki M, et al. Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: results of a 12-week, open label study. J Atheroscler Thrombosis. 2006;13:108–113

☆ Supported by Shanghai Leading Academic Discipline Project, Project number: Y0302.

PII: S0167-5273(07)01967-5

doi: 10.1016/j.ijcard.2007.10.034

International Journal of Cardiology
Volume 127, Issue 1 , Pages 33-39 , 23 June 2008

Article Tools

* Image Usage & Resolution